Insulin resistance and hypertension: The insulin resistance atherosclerosis study

Hypertension

Volumn 43, Issue 6, 2004, Pages 1324-1331

  Saad, Mohammed F ^a   Rewers, Marian ^b   Selby, Joseph ^c   Howard, George ^d   Jinagouda, Sujata ^a   Fahmi, Salwa ^a   Zaccaro, Dan ^d   Bergman, Richard N ^e   Savage, Peter J ^f   Haffner, Steven M ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DIVISION OF RESEARCH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Blood pressure; Diabetes; Hypertension; Insulin; Insulin resistance

Indexed keywords

INSULIN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RACE; SEX DIFFERENCE;

AFRICAN AMERICANS; ARTERIOSCLEROSIS; BLOOD PRESSURE; BODY MASS INDEX; CALIFORNIA; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HISPANIC AMERICANS; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; TEXAS;

EID: 2542419937     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000128019.19363.f9     Document Type: Article

References (40)

1. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966;1:1336-1337.
2. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
3. Reaven GM, Hoffman BB. A role for insulin in the aetiology and course of hypertension. Lancet. 1987;2:435-436.
4. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
5. Creager MA, Liang C-S, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther. 1985;235:709-714.
6. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men: a novel mechanism for insulin resistance. J Clin Invest. 1990;85:1844-1852.
7. Ferrannini E, Natali A, Capaldo B, Lehtovira M, Jacob S, Yki-Järvinen H, for the European Group for the Study of Insulin Resistance (EGIR). Insulin resistance, hyperinsulinemia, and blood pressure. Role of age and obesity. Hypertension. 1997;30:1144-1149.
8. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese men. J Clin Endocrinol Metab. 1986;62:1302-1304.
9. Rose HG, Yalow RS, Schweitzer E. Insulin as a potential factor influencing blood pressure in amputees. Hypertension. 1986;8:793-800.
10. Mbanya J-CN, Thomas TH, Wilkinson R, Alberti KGMM, Taylor R. Hypertension and hyperinsulinemia: a relation in diabetes but not essential hypertension. Lancet. 1988;1:733-734.
11. Verdecchia P, Gatteschi C, Benemio G, Guerrieri M, Porcellati C. Hyperinsulinemia and hypertension in diabetes. Lancet. 1988;2:242-244.
12. Zavaroni I, Mazza S, Dall'Aglio E, Gasparini P, Passseri M, Reaven GM. Prevalence of hyperinsulinemia in patients with high blood pressure. J Int Med. 1992;231:235-240.
13. Muscelli EOA, Saad MJA, Contijo JAR. Insulinemia and blood pressure responses to oral glucose load in primary hypertensive patients. Cardiology. 1991;79:14-19.
14. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall'Aglio E, Guerra L, Coscelli C, Butturini U. Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia. 1987;30:719-723.
15. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians. Diabetes. 1990;39:1430-1435.
16. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in nondiabetics. Metabolism. 1988;37:338-345.
17. Folsom AR, Burke GL, Ballew C, Jacobs DR Jr., Haskell WL, Donahue RP, Liu K, Hilner JE. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites; the role of insulin. Am J Epidemiol. 1989;130:911-924.
18. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Eschneider AE, Hales CN, Yudkin JS. The relationship of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 1990;33:532-537.
19. Manolio TA, Savage PJ, Burke GL, Liu K, Wagenknecht LE, Sidney S, Jacobs DR Jr., Roseman JM, Donahue RP, Oberman A. Association of fasting insulin with blood pressure and lipids in young adults: The CARDIA study. Arteriosclerosis. 1990;10:430-436.
20. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990;39:167-174.
21. Swislocki ALM, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1989;2:419-423.
22. Shen D-C, Sheih S-M, Fuh MM-T, Wu D-A, Chen Y-DI, Reaven GM. Resistance to insulin-stimulated glucose-uptake in patients with hypertension. J Clin Endocrinol Metab. 1988;66:580-583.
23. Cepaldo B, Lembo G, Napoli R, Rendina V, Albano G, Sacc L, Trimarco B. Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism. 1991;40:1320-1322.
24. Natali A, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension. 1991;17:170-178.
25. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, DeGregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-739.
26. Falkner B, Hulman S, Tannenbaum J, Kushner H. Insulin resistance and blood pressure in young black men. Hypertension. 1990;16:706-711.
27. Mattiasson I, Bemtorp K, Lindgarde F. Insulin resistance and Na+/K(+)-ATPase in hypertensive women: a difference in mechanism depending on the level of glucose tolerance. Clin Sci (Lond). 1992;82:105-111.
28. Wagenknecht LE, Mayer EJ, Rewers M, Haffner SM, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R. The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design, and recruitment results. Ann Epidemiol. 1995;5:464-471.
29. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsitivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed. 1986;23:113-122.
30. Welch S, Gebhart SSP, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab. 1990;71:1508-1518.
31. Saad MF, Anderson RL, Laws A, Watanabe R, Kades WW, Chen Y-DI, Sands RE, Savage PJ, Bergman RN. A comparison between the minimal model and the glucose clamp techniques in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes. 1994;43:1114-1121.
32. Coates PA, Luzio SD; Brunel P, Owens DR. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes. 1995;44:631-635.
33. Pollare T, Lithell H, Berne CN. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321:868-873.
34. Page M McB, Watkins PJ. Provocation of postural hypotension by insulin in diabetic autonomic neuropathy. Diabetes. 1976;25:90-95.
35. Heise T, Magnusson K, Heinemann L, Sawicki PT. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension. 1998;32:243-248.
36. Genev NM, Lau IT, Willey KA, Molyneaux LM, Xu ZR, Zilkens RR, Wyndham RN, Yue DK. Does insulin therapy have a hypertensive effect in type 2 diabetes. J Cardiovascular Pharmacol. 1998;32:39-41.
37. Wheatcroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med. 2003;20:255-268.
38. Aviv A, Gardner J. Racial difference in ion regulation and their possible links to hypertension in Blacks. Hypertension. 1989;14:584-589.
39. Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA. In vivo glucose metabolism in obese and type 2 diabetic subjects with or without hypertension. Diabetes. 1993;42:764-772.
40. Laakso M, Sarlund H, Mykkanen L. Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest. 1989;19:518-526.